Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 44  Show

Literature citations Results

Citation
Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors.

Kopecka J., Porto S., Lusa S., Gazzano E., Salzano G., Pinzon-Daza M.L., Giordano A., Desiderio V., Ghigo D., De Rosa G. et al.

Oncotarget 7:20753-20772(2016) · Mapped (1)

WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin.

Lo Muzio L., Pannone G., Staibano S., Mignogna M.D., Grieco M., Ramires P., Romito A.M., De Rosa G., Piattelli A.

Anticancer Res. 22:565-576(2002) · Mapped (1)

Tissue microarray-based evaluation of Chromatin Assembly Factor-1 (CAF-1)/p60 as tumour prognostic marker.

Mascolo M., Ilardi G., Merolla F., Russo D., Vecchione M.L., de Rosa G., Staibano S.

Int J Mol Sci 13:11044-11062(2012) · Mapped (2)

The proliferation marker Chromatin Assembly Factor-1 is of clinical value in predicting the biological behaviour of salivary gland tumours.

Staibano S., Mascolo M., Rocco A., Lo Muzio L., Ilardi G., Siano M., Pannone G., Vecchione M.L., Nugnes L., Califano L. et al.

Oncol. Rep. 25:13-22(2011) · Mapped (2)

The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy.

Pasquali D., Rossi V., Staibano S., De Rosa G., Chieffi P., Prezioso D., Mirone V., Mascolo M., Tramontano D., Bellastella A. et al.

Endocrinology 147:4245-4251(2006) · Mapped (6)

Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma.

De Maria S., Pannone G., Bufo P., Santoro A., Serpico R., Metafora S., Rubini C., Pasquali D., Papagerakis S.M., Staibano S. et al.

J. Cancer Res. Clin. Oncol. 135:107-116(2009) · Mapped (10)

Survivin expression in oral squamous cell carcinoma.

Lo Muzio L., Pannone G., Staibano S., Mignogna M.D., Rubini C., Mariggio M.A., Procaccini M., Ferrari F., De Rosa G., Altieri D.C.

Br. J. Cancer 89:2244-2248(2003) · Mapped (10)

Silencing the MET oncogene leads to regression of experimental tumors and metastases.

Corso S., Migliore C., Ghiso E., De Rosa G., Comoglio P.M., Giordano S.

Oncogene 27:684-693(2008) · Mapped (26)

Rs12979860 and rs8099917 single nucleotide polymorphisms of interleukin-28B gene: simultaneous genotyping in caucasian patients infected with hepatitis C virus.

Sticchi L., Di Biagio A., Rappazzo E., Setti M., De Rosa G., De Hoffer L., Nicolini L., Prinapori R., Bruzzone B.

J Prev Med Hyg 54:83-86(2013) · Mapped (2)

Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.

Simonetti S., Russo R., Ciancia G., Altieri V., De Rosa G., Insabato L.

Int. J. Surg. Pathol. 17:198-205(2009) · Mapped (13)

Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation.

De Stefano D., Villella V.R., Esposito S., Tosco A., Sepe A., De Gregorio F., Salvadori L., Grassia R., Leone C.A., De Rosa G. et al.

Autophagy 10:2053-2074(2014) · Mapped (73)

Recent outbreak of aseptic meningitis in Italy due to Echovirus 30 and phylogenetic relationship with other European circulating strains.

Milia M.G., Cerutti F., Gregori G., Burdino E., Allice T., Ruggiero T., Proia M., De Rosa G., Enrico E., Lipani F. et al.

J. Clin. Virol. 58:579-583(2013) · UniProtKB (10)

Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.

Mignogna C., Staibano S., Altieri V., De Rosa G., Pannone G., Santoro A., Zamparese R., D'Armiento M., Rocchetti R., Mezza E. et al.

BMC Cancer 6:293-293(2006) · Mapped (15)

Preoperative administration of GnRH-a plus tibolone to premenopausal women with uterine fibroids: evaluation of the clinical response, the immunohistochemical expression of PDGF, bFGF and VEGF and the vascular pattern.

Di Lieto A., De Falco M., Mansueto G., De Rosa G., Pollio F., Staibano S.

Steroids 70:95-102(2005) · Mapped (30)

PIEZO1-R1864H rare variant accounts for a genetic phenotype-modifier role in dehydrated hereditary stomatocytosis.

Andolfo I., Manna F., De Rosa G., Rosato B.E., Gambale A., Tomaiuolo G., Carciati A., Marra R., De Franceschi L., Iolascon A. et al.

Haematologica 103:e94-e97(2018) · Mapped (3)

P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas.

Lo Muzio L., Pannone G., Mignogna M.D., Staibano S., Mariggio M.A., Rubini C., Procaccini M., Dolci M., Bufo P., De Rosa G. et al.

Histol. Histopathol. 19:1089-1099(2004) · Mapped (2)

p66Shc deletion confers vascular protection in advanced atherosclerosis in hypercholesterolemic apolipoprotein E knockout mice.

Martin-Padura I., de Nigris F., Migliaccio E., Mansueto G., Minardi S., Rienzo M., Lerman L.O., Stendardo M., Giorgio M., De Rosa G. et al.

Endothelium 15:276-287(2008) · Mapped (10)

Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness.

Celetti A., Testa D., Staibano S., Merolla F., Guarino V., Castellone M.D., Iovine R., Mansueto G., Somma P., De Rosa G. et al.

Clin. Cancer Res. 11:8019-8027(2005) · Mapped (11)

Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients.

Mascolo M., Vecchione M.L., Ilardi G., Scalvenzi M., Molea G., Di Benedetto M., Nugnes L., Siano M., De Rosa G., Staibano S.

BMC Cancer 10:63-63(2010) · Mapped (2)

Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer.

Staibano S., Mascolo M., Mancini F.P., Kisslinger A., Salvatore G., Di Benedetto M., Chieffi P., Altieri V., Prezioso D., Ilardi G. et al.

Histopathology 54:580-589(2009) · Mapped (2)

OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome.

Staibano S., Merolla F., Testa D., Iovine R., Mascolo M., Guarino V., Castellone M.D., Di Benedetto M., Galli V., Motta S. et al.

Br. J. Cancer 97:1545-1551(2007) · Mapped (27)

Novel parkin mutations detected in patients with early-onset Parkinson's disease.

Italian Parkinson Genetics Network
Bertoli-Avella A.M., Giroud-Benitez J.L., Akyol A., Barbosa E., Schaap O., van der Linde H.C., Martignoni E., Lopiano L., Lamberti P., Fincati E. et al.

Mov. Disord. 20:424-431(2005) · UniProtKB (1) · Mapped (22)

Novel Gardos channel mutations linked to dehydrated hereditary stomatocytosis (xerocytosis).

Andolfo I., Russo R., Manna F., Shmukler B.E., Gambale A., Vitiello G., De Rosa G., Brugnara C., Alper S.L., Snyder L.M. et al.

Am. J. Hematol. 90:921-926(2015) · UniProtKB (1) · Mapped (3)

Mycophenolate mofetil and roscovitine decrease cyclin expression and increase p27(kip1) expression in anti Thy1 mesangial proliferative nephritis.

Chiara M., Menegatti E., Di Simone D., Davit A., Bellis D., Sferch D., De Rosa G., Giachino O., Sena L.M., Roccatello D.

Clin. Exp. Immunol. 139:225-235(2005) · Mapped (2)

MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.

de Antonellis P., Medaglia C., Cusanelli E., Andolfo I., Liguori L., De Vita G., Carotenuto M., Bello A., Formiggini F., Galeone A. et al.

PLoS ONE 6:e24584-e24584(2011) · Mapped (19)

1 to 25 of 44  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again